Artificial intelligence for advance requesting of immunohistochemistry in diagnostically uncertain prostate biopsies

Author:

Chatrian AndreaORCID,Colling Richard T.,Browning Lisa,Alham Nasullah Khalid,Sirinukunwattana KorsukORCID,Malacrino StefanoORCID,Haghighat MaryamORCID,Aberdeen Alan,Monks Amelia,Moxley-Wyles BenjaminORCID,Rakha Emad,Snead David. R. J.,Rittscher Jens,Verrill ClareORCID

Abstract

AbstractThe use of immunohistochemistry in the reporting of prostate biopsies is an important adjunct when the diagnosis is not definite on haematoxylin and eosin (H&E) morphology alone. The process is however inherently inefficient with delays while waiting for pathologist review to make the request and duplicated effort reviewing a case more than once. In this study, we aimed to capture the workflow implications of immunohistochemistry requests and demonstrate a novel artificial intelligence tool to identify cases in which immunohistochemistry (IHC) is required and generate an automated request. We conducted audits of the workflow for prostate biopsies in order to understand the potential implications of automated immunohistochemistry requesting and collected prospective cases to train a deep neural network algorithm to detect tissue regions that presented ambiguous morphology on whole slide images. These ambiguous foci were selected on the basis of the pathologist requesting immunohistochemistry to aid diagnosis. A gradient boosted trees classifier was then used to make a slide-level prediction based on the outputs of the neural network prediction. The algorithm was trained on annotations of 219 immunohistochemistry-requested and 80 control images, and tested by threefold cross-validation. Validation was conducted on a separate validation dataset of 222 images. Non IHC-requested cases were diagnosed in 17.9 min on average, while IHC-requested cases took 33.4 min over multiple reporting sessions. We estimated 11 min could be saved on average per case by automated IHC requesting, by removing duplication of effort. The tool attained 99% accuracy and 0.99 Area Under the Curve (AUC) on the test data. In the validation, the average agreement with pathologists was 0.81, with a mean AUC of 0.80. We demonstrate the proof-of-principle that an AI tool making automated immunohistochemistry requests could create a significantly leaner workflow and result in pathologist time savings.

Funder

RCUK | Medical Research Council

DH | National Institute for Health Research

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Reference34 articles.

1. World Cancer Research Fund. Worldwide cancer data: Global cancer statistics for the most common cancers. 2018. https://www.wcrf.org/dietandcancer/cancer-trends/worldwide-cancer-data.

2. Cancer Research UK. Prostate Cancer Statistics. 2021. https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/prostate-cancer#heading-Three (2021).

3. The Royal College of Pathologists. Histology Workforce Survey 2018. 2018. https://www.rcpath.org/profession/workforce-planning/our-workforce-research/histopathology-workforce-survey-2018.html.

4. Cross T, McPhail S. In: Prostate Cancer: Diagnosis and Treatment (Supplement): An Assessment of Need National Institute for Health and Clinical Excellence: Guidance. Cardiff (UK): National Collaborating Centre for Cancer (NCC-C); 2008.

5. Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM. Complications after prostate biopsy: data from SEER-Medicare. J Urol. 2011;186:1830–4.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3